XEN Gel Implant: a new surgical approach in glaucoma

References

• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.
   PubMed Web of Science ®Google Scholar
• Nickells RW, Howell GR, Soto I, et al. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci. 2012;35:153–179.
   PubMed Web of Science ®Google Scholar
• Boland MV, Ervin AM, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2013;158:271–279.
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol. 2002;120:1268–1279.
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology Preferred Practice Patterns Committee GP. Ophthalmology. Chicago (IL): American Academy of Ophthalmology; 2010. Preferred practice pattern: primary open-angle glaucoma.
   Google Scholar
• Olthoff CM, Schouten JS, van de Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmol. 2005;112:953–961.
   PubMed Web of Science ®Google Scholar
• Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118:2398–2402.
   PubMed Web of Science ®Google Scholar
• Prager AJ, Liebmann JM, Cioffi GA, et al. Self-reported function, health resource use, and total health care costs among Medicare beneficiaries with glaucoma. JAMA Ophthalmol. 2016;134:357–365.
   PubMed Web of Science ®Google Scholar
• Toteberg-Harms M, Berlin MS, Meier-Gibbons F. Increasing healthcare costs: can we influence the costs of glaucoma care? Curr Opin Ophthalmol. 2017;28:127–132.
   PubMed Web of Science ®Google Scholar
• Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176–181.
   PubMedGoogle Scholar
• Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty: a 10-year follow-up study. Ophthalmology. 1993;100:1324–1329.
   PubMed Web of Science ®Google Scholar
• Shingleton BJ, Richter CU, Bellows AR, et al. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology. 1987;94:1513–1518.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2005;140:16–22.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.
   PubMed Web of Science ®Google Scholar
• Skuta GL, Parrish RK II. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149–170.
   PubMed Web of Science ®Google Scholar
• Edmunds B, Thompson JR, Salmon JF, et al. The National Survey of Trabeculectomy. III. Early and late complications. Eye. 2002;16:297–303.
   PubMed Web of Science ®Google Scholar
• Saheb H, Gedde SJ, Schiffman JC, et al. Outcomes of glaucoma reoperations in the tube versus trabeculectomy (TVT) study. Am J Ophthalmol. 2014;157:1179.e2–89.e2.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–814.
   PubMed Web of Science ®Google Scholar
• Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131:1573–1582.
   PubMed Web of Science ®Google Scholar
• Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96–104.
   PubMed Web of Science ®Google Scholar
• Brandão LM, Grieshaber MC. Update on minimally invasive glaucoma surgery (MIGS) and new implants. J Ophthalmol. 2013;2013:705915.
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459–467.
   PubMed Web of Science ®Google Scholar
• Craven ER, Katz LJ, Wells JM, et al. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339–1345.
   PubMed Web of Science ®Google Scholar
• Camras LJ, Yuan F, Fan S, et al. A novel Schlemm’s canal scaffold increases outflow facility in a human anterior segment perfusion model. Invest Ophthalmol Vis Sci. 2012;53:6115–6121.
   PubMed Web of Science ®Google Scholar
• Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a Schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122:1283–1293.
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Toris CB, Gabelt BT, et al. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47:S53–64.
   PubMed Web of Science ®Google Scholar
• Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30:233–238.
   PubMed Web of Science ®Google Scholar
• Razeghinejad MR, Spaeth GL. A history of the surgical management of glaucoma. Optom Vis Sci. 2011;88:E39–47.
   PubMed Web of Science ®Google Scholar
• Hoeh H, Ahmed IIK, Grisanti S, et al. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery. J Cataract Refract Surg. 2013;39:431–437.
   PubMed Web of Science ®Google Scholar
• Ho ̈H H, Grisanti S, Grisanti S, et al. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsbla ̈Tter Fu ̈ R Augenheilkd. 2014;231:377–381.
   PubMed Web of Science ®Google Scholar
• Yu D-Y, Morgan WH, Sun X, et al. The critical role of the conjunctiva in glaucoma filtration surgery. Prog Retin Eye Res. 2009;28:303–328.
   PubMed Web of Science ®Google Scholar
• Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. 2014;40:1301–1306.
   PubMed Web of Science ®Google Scholar
• Sheybani A, Reitsamer H, Ahmed IIK. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci. 2015;56:4789–4795.
   PubMed Web of Science ®Google Scholar
• Sheybani A, Lenzhofer M, Hohensinn M, et al. Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg. 2015;41:1905–1909.
   PubMed Web of Science ®Google Scholar
• Sheybani A, Dick B, Ahmed IIK. Early clinical results of a novel ab interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma. 2016;25:e691–e696.
   PubMed Web of Science ®Google Scholar
• Galal A, Bilgic A, Eltanamly R, et al. XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol. 2017;2017:5457246.
   PubMedGoogle Scholar
• Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M, et al. Combined phacoemulsification and Xen45 surgery from temporal approach and 2 incisions. Arch Soc Esp Oftalmol. 2016 Sep;91:415–421.
   PubMedGoogle Scholar
• Singh K, Lee BL, Wilson MR. Glaucoma Modified RAND-Like Methodology Group A panel assessment of glaucoma management: modification of existing RAND-like methodology consensus in ophthalmology. Part II: results and interpretation. Am J Ophthalmol. 2008;145:575–581.
   PubMed Web of Science ®Google Scholar
• Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, et al. Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract. Br J Ophthalmol. 2013;97:1250–1255.
   PubMed Web of Science ®Google Scholar
• De Gregoria A, Pedrotti E, Russo L, et al. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol. 2017. doi: 10.1007/s/0792-017-0571-x [Epub ahead of print].
   Google Scholar
• Fea AM, Spinetta R, Cannizzo PML, et al. Evaluation of bleb morphology and reduction in IOP and glaucoma medication following implantation of a novel gel stent. J Ophthalmol. 2017;2017:9364910.
   PubMedGoogle Scholar
• Chen PP, Lin SC, Junk AK, et al. The effect of phacoemulsification on intraocular pressure in glaucoma patients: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122:1294–1307.
   PubMed Web of Science ®Google Scholar
• Pinto Ferreira N, Abegao Pinto L, Marques-Neves C. XEN gel stent internal ostium occlusion: ab-interno revision. J Glaucoma. 2017;26:e150–2.
   PubMed Web of Science ®Google Scholar
• Dervenis N, Mikropoulou AM, Dervenis P, et al. Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report. BMC Ophthalmol. 2017;17:148.
   PubMed Web of Science ®Google Scholar
• Sng CC, Wang J, Hau S, et al. XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol. 2017. doi: 10.1111/ceo.13087. [Epub ahead of print].
   PubMedGoogle Scholar
• Prokosch WV, Vossmerbaeumer U, Hoffmann E, et al. Suprachoroidal bleeding after XEN gel implantation. J Glaucoma. 2017;26:e261–63.
   PubMed Web of Science ®Google Scholar
• Olate-Pérez A, Perez-Torregrosa VT, Gargallo-Benedicto A, et al. Management of conjunctival perforation and late Seidel after XEN® surgery. Arch Soc Esp Oftalmol. 2017. doi: 10.1016/j.oftal.2017.10.002. [Epub ahead of print].
   Google Scholar
• Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124:1579–1588.
   Web of Science ®Google Scholar
• Salinas L, Chaudhary A, Guidotti J, et al. Revision of a leaking bleb with XEN gel stent replacement. J Glaucoma. 2017. doi: 10.1097/IJG.0000000000000811. [Epub ahead of print].
   Google Scholar
• Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Kalenak JW, Zurakowski D, et al. The Ahmed versus Baerveldt study: one-year treatment outcomes. Ophthalmology. 2011;118:2180–2189.
   PubMed Web of Science ®Google Scholar
• Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976.
   PubMed Web of Science ®Google Scholar
• Barton K, Feuer WJ, Budenz DL, et al. Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2014;121:1547–57.e1.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Barton K, Feuer WJ, et al. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology. 2011;118:443–452.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Feuer WJ, Barton K, et al. Postoperative complications in the Ahmed Baerveldt Comparison Study during five years of follow-up. Am J Ophthalmol. 2016;163:75–82.e3.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Preferred practice pattern: primary open-angle glaucoma. San Francisco: Elsevier; 2015.
   Google Scholar
• D’Alessandro E, Guidotti JM, Mansouri K, et al. XEN-augmented Baerveldt: a new surgical technique for refractory glaucoma. J Glaucoma. 2017;26:e90–2.
   PubMed Web of Science ®Google Scholar
• Sng CCA, Wang J, Barton K. Caution in using the XEN-augmented Baerveldt surgical technique. J Glaucoma. 2017;26:e257.
   PubMed Web of Science ®Google Scholar
• D’Alessandro E, Guidotti JM, Mansouri K, et al. Caution in using the XEN-augmented Baerveldt surgical technique. J Glaucoma. 2017. doi: 10.1097/IJG.0000000000000638. [Epub ahead of print].
   Web of Science ®Google Scholar
• Hohberger B, Welge-Lüen VC, Lämmer R. ICE-syndrome: a case report of implantation of a microbypass XEN gel stent after DMEK transplantation. J Glaucoma. 2017;26:e103–4.
   PubMed Web of Science ®Google Scholar